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Abstract
Background: Perinatal common mental disorders are associated with significant adverse outcomes for women and
their families, particularly in low- and middle-income settings. Early detection through screening with locally-
validated tools can improve outcomes.
Methods: We searched MEDLINE, Embase, PsycINFO, Global Health, Cochrane Library, Web of Science and Google
Scholar for articles on the validation of screening tools for common mental disorders in perinatal women in India,
with no language or date restrictions. Quality was assessed using the QUADAS-2 tool. We used bivariate and
hierarchical summary receiver operating characteristic models to calculate pooled summary estimates of sensitivity
and specificity. Heterogeneity was assessed by visualising the distance of individual studies from the summary
curve.
Results: Seven studies involving 1003 women were analysed. All studies assessed the validity of the Edinburgh
Postnatal Depression Scale (EPDS) in identifying perinatal depression. No validation studies of any other screening
tools were identified. Using a common threshold of ≥13 the EPDS had a pooled sensitivity and specificity of 88·9%
(95%CI 77·4–94·9) and 93·4 (95%CI 81·5–97·8), respectively. Using optimal thresholds (range ≥ 9 to ≥13) the EPDS
had a pooled sensitivity and specificity of 94·4% (95%CI 81·7–98·4) and 90·8 (95%CI 83·7–95·0), respectively.
Conclusion: The EPDS is psychometrically valid in diverse Indian settings and its use in routine maternity care
could improve detection of perinatal depression. Further research is required to validate screening tools for other
perinatal common mental disorders in India.
Keywords: Common mental disorder, Screening, Low- and middle-income country (LMIC), Validation, Systematic
review, India, Perinatal
Background
Globally, mental health disorders are among the greatest
contributors to maternal morbidity and mortality, with
low- and middle-income countries (LMIC) carrying the
greatest burden [1]. Common mental disorders (CMD)
refer to depressive and anxiety disorders, which repre-
sent the most prevalent categories of mental health dis-
orders [2]. CMD experienced in the perinatal period
(during pregnancy or the first twelve months post-
partum) are associated with significant and potentially
long-term consequences for women and their families
[3]. In LMIC in particular, infants of mothers with
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mental disorders have a higher risk of adverse physical,
cognitive and behavioural outcomes including low birth-
weight, stunting, infectious illnesses and delayed devel-
opment [3, 4]. Meta-analyses from LMIC have reported
pooled prevalence estimates of 19% for perinatal depres-
sion [5], and 34 and 26% for antenatal and postnatal
anxiety [6], respectively, although estimates from indi-
vidual settings vary according to population characteris-
tics, socio-cultural factors and methodological variations.
Early detection and treatment of perinatal CMD is es-
sential to minimise adverse effects and improve out-
comes for women and their families [7, 8]. However,
stigma around mental health disorders, competing clin-
ical priorities, a lack of expertise, no systematic means of
detection and poor mental health service infrastructure
mean that in many LMICs women with mental disorders
remain unidentified, unsupported and untreated. Screen-
ing for CMD symptoms offers a systematic and efficient
means of identifying women likely to have mental health
disorders [7, 8]. Screening tools must be validated locally
against a ‘gold standard’ diagnostic interview prior to
use to assess their validity, establish the appropriate
diagnostic thresholds and ensure their cultural appropri-
ateness and acceptability [9]. Without formal validation,
the reliability of screening tools in a setting or popula-
tion different from that in which the tool was developed
is not guaranteed. Screening with an inappropriately
high threshold risks under-detection of women with
CMD, while a threshold that is too low risks creating
high levels of demand, placing strain on already over-
burdened health systems [10]. Furthermore, the lack of
validation brings into question the reliability of preva-
lence estimates from a variety of settings, as most preva-
lence studies rely on the use of screening tools to
determine caseness. A previous review of screening tools
for CMD highlighted a shortage of validation studies
from LMIC, with particular gaps in screening tools for
anxiety disorders [11].
In India, an estimated 18 and 22% of women experi-
ence antenatal [12] and postnatal [13] depression, re-
spectively, while perinatal anxiety has not been
systematically studied. Stigma towards mental disorders
remains widespread nationally, and women living in
socio-economic deprivation, those experiencing intimate
partner violence and those with low societal status are at
particularly high risk of perinatal mental disorders [14,
15]. Although there have been initiatives to improve ma-
ternal health, there has been less focus on maternal
mental health and services in this area are lacking [14].
There is no screening initiative recommended for rou-
tine use in maternity services [13]. Without a systematic
synthesis of Indian validation studies there remains un-
certainty around which screening tools might be suitable
for use in perinatal populations in India. Improving the
detection of perinatal mental disorders is key to better
CMD management and to achieving many of the United
Nation’s Sustainable Development Goals [16]. The
current review fills an important literature gap by syn-
thesising the current evidence about validated screening
tools for perinatal CMD in India, thereby providing
evidence-based data for screening initiatives that can im-
prove women’s wellbeing across India.
Methods
Search strategy and selection criteria
References for this systematic review and meta-analysis
were identified through searches of MEDLINE, Embase,
PsycINFO, Global Health, the Cochrane library and
Web of Science using a combination of MeSH and free-
text terms pertaining to perinatal status, common men-
tal disorders, validation and India. The full search strat-
egy is detailed in the Additional file 1. In order to
maximise inclusivity, no date or language restrictions
were used. Non-indexed journal articles and grey litera-
ture were identified through searches of the National
Database of Indian Medical Journals (MedIND), the
World Health Organisation (WHO), the United Nations
Children’s Fund, the Government of India Ministry of
Health and Family Welfare and Google Scholar. Refer-
ence lists of relevant studies were manually searched to
identify further eligible studies. Studies of perinatal
women of any age, in any trimester of pregnancy and up
to twelve months post-partum and living in India were
included. Studies of Indian nationals living abroad were
excluded. Studies of any design were included if they
assessed the performance of a CMD screening tool
against a diagnostic interview. Studies of screening tools
assessing quality of life or maternal-infant bonding were
excluded. Studies which compared one screening tool to
another (rather than to a diagnostic interview) were in-
cluded but this limitation was reflected in the study’s
quality assessment rating. No studies were excluded on
the basis of quality. The primary outcome was measures
of psychometric validity including sensitivity, specificity,
area under the receiver operating characteristic (ROC)
curve (AUC) and optimal cut-off thresholds of the
screening tool. Secondary outcomes were the acceptabil-
ity and ease of administration of the tool, and CMD
prevalence as determined by diagnostic interviews. The
final search was conducted on 16 April 2020. This study
was registered with PROSPERO (CRD42019153711)
Screening, data extraction and risk of bias assessment
This review was carried out in accordance with the Pre-
ferred Reporting Items for Systematic Review and Meta-
Analysis (PRISMA) guidelines [17]. Two reviewers (GF,
SH) independently screened titles and abstracts using
Covidence software to identify potentially eligible studies
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[18]. Full-texts of these studies were retrieved and
screened independently by the same reviewers. Disagree-
ments were resolved by discussion with a third reviewer
(FA). For included studies, two reviewers (GF, SH) inde-
pendently extracted data about study design and setting,
participant characteristics, screening tool, diagnostic
interview and results using a standardised, pre-piloted
form (Additional file 2). Discrepancies were resolved
through discussion with a third reviewer (FA). Study au-
thors were contacted by email to retrieve missing infor-
mation; up to two reminder emails were sent if no
response was received to the first. Risk of bias was
assessed using the Quality of Diagnostic Accuracy
Studies-2 (QUADAS-2) tool which assesses patient se-
lection (recruitment and inclusion criteria), index test
and reference standard (how tests were conducted and
interpreted), and the flow and timing (flow of partici-
pants through the study and time interval between tests)
[19]. We added questions to assess for: (i) use of a clear
and concise perinatal time period; (ii) adequate sample
size; (iii) adherence to the WHO protocol for translation
and adaptation of instruments into local languages [20];
and (iv) qualifications of diagnostic interviewers (Add-
itional file 3). A minimum of 150 participants was con-
sidered a good sample size [21–23]. Two reviewers (GF,
SH) assessed risk of bias for each included study and dis-
cussed discrepancies with a third reviewer (FA).
Data analysis
A narrative synthesis of results was conducted to provide
an overview of included studies. Meta-analysis was con-
ducted for studies which validated the same screening
tool and reported sufficient data [24]. Data on true posi-
tives (TP), true negatives (TN), false positives (FP) and
false negatives (FN) was used to plot the sensitivity and
specificity of each study in a scatterplot, illustrating the
location of data points and any relationship between
sensitivity and specificity seen across studies. A pooled
summary estimate of sensitivity and specificity was cal-
culated by fitting two hierarchical models that account
for the threshold effect of diagnostic studies: the bivari-
ate model and the hierarchical summary receiver operat-
ing characteristic (HSROC) model [25]. For each study
included in meta-analysis, the TP, TN, FP and FN data
were extracted for (i) the optimal cut-off and (ii) a com-
mon (standard) threshold. The optimal cut-off was the
threshold which was identified by original studies as
maximising sensitivity and specificity in that particular
setting. This optimal threshold varied across studies. In
addition, data was extracted on a common threshold: we
used the standard cut-off of ≥13 and applied the sensi-
tivity and specificity at this threshold from original stud-
ies. The reason for including both optimal and common
thresholds was that the former assesses the performance
of the EPDS using locally-determined, ideal cut-offs,
while the latter provides a comparison of the EPDS per-
formance across different settings using a standardised
cut-off. HSROC plots were drawn to illustrate the
pooled estimate of sensitivity and specificity (summary
point) using optimal and common fixed thresholds along
with 95% confidence regions [25]. Subgroup analyses
were planned a-priori according to perinatal status, geo-
graphic region, language, and study quality. Heterogen-
eity in test accuracy was assessed by visualising the
distance of individual studies from the summary ROC
curve, and publication bias was explored using a scatter-
plot of the inverse square effective sample size (ESS) ver-
sus the diagnostic odds ratio (DOR) [24]. All analyses
were conducted using STATA version 14.2 [26].
Results
We identified 8306 publications through electronic data-
base searches, of which 2838 were duplicates (Fig. 1). Of
the 5468 records screened by title and abstract, 78 were
included in full-text screening. Of these full-texts, 76
were excluded for reasons listed in Fig. 1. Five additional
journal articles were identified through grey literature
searches. Seven studies [27–33] met the criteria for in-
clusion in the review and six [27–32] were included in
meta-analysis; it was not possible to include the seventh
study [33] because this study did not report participant
numbers. Characteristics of included studies are shown
in Table 1. Studies were all cross-sectional and included
data for over 1003 rural and urban perinatal women in
total (one study did not report participant numbers).
Settings were geographically diverse, including Assam in
the Northeast [31]; Gujarat [28], Maharasthra [32] and
Goa [33] in the West; Madhya Pradesh in central India
[30]; and Karnataka [29] and Tamil Nadu [27] in the
South. Screening tool languages included Hindi [30], As-
samese [31], Gujarati [28], Kannada [29], Konkani [33],
Marathi [32], and Tamil [27]. Four studies included
post-partum women [27, 28, 31, 32], two included preg-
nant women [29, 30], and one study did not report the
timing of assessment [33].
All of the included studies validated the Edinburgh
Postnatal Depression Scale (EPDS) as a screening tool
for depression. No studies were identified which vali-
dated any other CMD screening tool. Six studies [27–29,
31–33] validated the EPDS against a diagnostic interview
and one [30] compared the EPDS to another screening
tool (Patient Health Questionnaire-9; PHQ-9). Fer-
nandes et al. (2011) simultaneously validated the EPDS
and the Kessler-10 (K10) scale against a diagnostic inter-
view [29]. All screening tools were administered verbally
by healthcare workers or researchers. Diagnostic inter-
views used as the comparators included the Clinical
Interview Schedule (Revised) (CIS-R), Mini-International
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Neuropsychiatric Interview (MINI-Plus) and semi-
structured psychiatric interviews based on ICD-10 cri-
teria. Optimal EPDS cut-offs identified in individual
studies ranged between ≥927 and ≥13 [29, 31, 32]. Sensi-
tivity and specificity at these optimal cut-offs ranged be-
tween 65·4–100% [28, 29] and 79·7–98% [28, 30],
respectively. The AUC at these optimal thresholds
ranged between 0·7346–0·999 [28, 30] across five studies
which reported this metric. When a common threshold
of ≥13 was applied across all studies, including the three
studies for which this was not the optimal threshold,
sensitivity and specificity of the EPDS ranged between
64·7–100% [27, 29] and 84·8–100% [28, 29], respectively.
Three studies explored the acceptability of screening
tools to participating women and healthcare staff. Benja-
min et al. (2005) and Desai et al. (2011) reported ease of
administration of the EPDS due to its brevity and avoid-
ance of technical terms [27, 28]. Desai et al. (2011)
found that the EPDS took on average five minutes to
complete, and that the tool itself, as well as the wider
concept of routine screening for post-partum depression,
were feasible and acceptable to participants [28].
Fernandes et al. (2011) found that in comparison to the
K10, the EPDS was more difficult to administer due to
its changing response options which were time-
consuming to explain [29]. However, the EPDS was bet-
ter than the K10 at excluding somatic symptoms of
pregnancy [29]. Khapre (2017) did not directly assess ac-
ceptability to participants but reported that no linguistic
ambiguity was found in the translated EPDS and that
the screen took 7–10 min on average to complete [32].
The prevalence of depression as measured using diag-
nostic interviews was reported by four studies and
ranged between 12.5% [28] and 18% [31].
Six studies (1003 participants) were included in meta-
analysis [27–32]. Fig. 2 shows scatterplots of the sensitiv-
ity and specificity of each study using optimal thresholds
and a common threshold of ≥13. Optimal thresholds
ranged from ≥9 to ≥13. Using these optimal thresholds,
Desai et al. (2011) had the highest sensitivity and specifi-
city, Joshi et al. (2020) had the lowest and the remaining
studies were located in between. At a threshold of ≥13,
Desai et al. (2011), Khapre et al. (2017) and Fernandes
et al. (2011) had the highest sensitivities and specificities,
Fig. 1 Study selection
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followed by Kalita et al. (2008), Benjamin et al. (2005)
and Joshi et al. (2020). Figure 3 shows the HSROC
curves along with summary points of pooled sensitivity
and specificity and 95% confidence regions using optimal
and common thresholds. Using optimal thresholds, the
pooled sensitivity estimate was 94·4% (95% CI 81·7–98·4)
and the pooled specificity estimate was 90·8 (95% CI
83·7–95·0). Using a common threshold of ≥13, the
pooled sensitivity estimate was 88·9% (95% CI 77·4–94·9)
and the pooled specificity estimate was 93·4 (95% CI
81·5–97·8). The small number of studies available for
meta-analysis precluded subgroup analyses. There was
no evidence of publication bias, as shown by the lack of
association between the inverse square roots of the ef-
fective sample sizes of the included studies and their es-
timated diagnostic odds ratios (Additional file 4). Study
quality varied by domains assessed (Table 2). Two
studies were considered to be at low risk of bias across
all domains [28, 29], and two studies were considered to
be at high risk of bias across one or more domains [30,
31].
Discussion
This systematic review and meta-analysis synthesises
data from validation studies of screening tools for peri-
natal CMDs in India. Seven studies were identified, all of
which assessed the validity of the EPDS in identifying
perinatal depression. Although the review aimed to as-
sess validation studies of any CMD screening tools, no
validation studies of any mental disorders other than de-
pression, nor of any screening tools other than the
EPDS, were identified. Studies included in the review re-
ported good psychometric performance of the EPDS
with optimal thresholds ranging from ≥9 to ≥13. Using
Fig. 2 Scatterplot of sensitivity vs. specificity of the EPDS for detecting depression in each study using optimal thresholds (left panel) and
common threshold of ≥13 (right panel)
Fig. 3 Hierarchical summary receiver operating characteristic (HSROC) curve using optimal threshold (left panel) and common threshold of ≥13
(right panel)
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optimal thresholds, the pooled sensitivity and specificity
were 94·4% and 90·8%, respectively. When a common
EPDS threshold of ≥13 was applied across all studies,
the pooled sensitivity and specificity were not substan-
tially different at 88·9% and 93·4%, respectively. Overall,
these findings suggest that the EPDS is a psychometric-
ally valid tool that can reliably detect women with peri-
natal depression across diverse settings and languages in
India.
Our pooled estimates suggest that EPDS sensitivity is
maximised when an optimal threshold, identified
through the formal validation of the tool in the local
context and population, is applied. Validity in one set-
ting or population does not imply validity elsewhere, and
especially in a country as culturally, linguistically and so-
cially diverse as the Indian subcontinent, local validation
to suit local needs is the ideal practice [11, 34–36]. Pre-
vious studies have highlighted differences in optimal
thresholds across locations. In a review of EPDS validity
across LMIC settings, optimal thresholds ranged from 4
to 12, with sensitivity and specificity ranging from 69·7–
100% and 36·1–97%, respectively [10]. These differences
are likely the combined results of several factors includ-
ing cultural differences in manifestations of depression,
population characteristics and methodological differ-
ences such as mode of assessment [34, 37].
To assess the EPDS’ performance at a fixed threshold,
we selected a cut-off of ≥13 which is one of the most
commonly-used thresholds globally [37]. This cut-off
was also recommended by the original EPDS authors as
being indicative of ‘probable depression’ [38]. At a
common threshold of ≥13 the pooled sensitivity of the
EPDS decreased, but only marginally, from 94·4% to
88·9%, while the pooled specificity increased marginally
from 90·8% to 93·4%. Among individual studies, there
was variability in EPDS performance at this cut-off: Fer-
nandes et al. (2011) reported 100% sensitivity among
pregnant women in rural Karnataka while Benjamin
et al. (2005) reported a sensitivity of 64·7% among post-
partum women in rural Tamil Nadu [27, 29]. Language
and cultural factors may have played a role in these dif-
ferences, along with the different perinatal stage (preg-
nant vs. post-partum) of participants. These differences
highlight the importance of local validation and adapta-
tion of the threshold whenever possible. However, we
acknowledge that resources and capacity to conduct
local validation studies using robust methodology may
not always be available in LMIC settings, where existing
services are already stretched. When local validation is
not feasible, our results suggest that a standardised
threshold, the validity of which has been demonstrated
in a similar population and setting, may provide a next-
best alternative with only a marginal decrease in test
performance.
The acceptability of an instrument to respondents and
healthcare workers is a crucial aspect of screening yet
often remains overlooked. A screening tool that is diffi-
cult or time-consuming will have limited utility and is
unlikely to be sustainable in routine care. The three
studies in our review which explored the acceptability of
the EPDS all reported ease-of-use and good acceptability
[27–29]. However, the only study to compare the EPDS
Table 2 Risk of bias (quality) of studies included in review as assessed using QADAS-2
low risk of bias; unclear risk of bias; high risk of bias
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to another screening tool found that the alternative, the
K10, was quicker and more straightforward to adminis-
ter [29]. The EPDS is generally considered to have good
acceptability across diverse settings [34, 37, 39, 40].
However, challenges have been reported in some set-
tings. In a study of migrant and refugee women in
Thailand, participants and staff found the EPDS difficult
to use and time-consuming, rendering it unsuitable for
the local context [41]. In the UK, a review of the accept-
ability of the EPDS found that although the tool was
generally well-accepted postnatally, women found some
EPDS items difficult and questioned the cultural specifi-
city of the tool [42]. Our review found that the preva-
lence of perinatal depression in various states in India
using diagnostic interviews ranged from 12·5 to 18%.
This range is lower than previous estimates derived from
screening tools, which tend to over-estimate prevalence
[12, 13]. Our prevalence range may provide a more ac-
curate estimate of the true burden of perinatal depres-
sion in India.
The quality of included studies varied. While several
studies scored well across all domains, some weak areas
were seen across studies. Few studies explicitly reported
following the standardised WHO protocol for the trans-
lation and adaptation of tools [20]. Exclusion criteria
were another weakness. Joshi et al. (2020) excluded
women with a previous history of severe mental dis-
order, suicidal ideation or anti-depressant medication,
and Kalita et al. (2008) excluded women with past sub-
stance misuse or on long-term medication [30, 31].
These exclusions are problematic given the correlation
between these factors and perinatal depression, and may
have limited the generalisability of findings to the wider
community.
The general paucity of evidence around validation of
screening tools for perinatal CMD in India is of concern.
The existing evidence is narrow in scope, focusing en-
tirely on perinatal depression and almost exclusively on
the EPDS. Although the EPDS appears to be a psycho-
metrically sound and generally well-accepted tool, the
lack of research on alternative depression screening tools
means we cannot make overall recommendations for the
EPDS over other tools. Other CMDs and also common
and often co-morbid with perinatal depression [6]. Stud-
ies to assess the validity of screening tools for these con-
ditions are an urgent research priority. Five of the seven
studies in this review were identified through grey litera-
ture searches. Although these were journal publications,
they appeared in non-indexed journals and were there-
fore not retrieved by our medical database searches. The
absence of these studies from the most commonly used
databases for reviewing the medical literature highlights
the importance of looking beyond indexed journals in
order to avoid missing important and relevant studies.
India has seen a steady decline in maternal mortality
in recent years and this presents an opportunity to shift
focus to addressing maternal morbidity [13]. Given the
significant associations between perinatal CMD and the
well-being of women, their children, families and wider
society, the identification and appropriate management
of perinatal CMDs must not be sidelined. The perinatal
period is a time of increased contact between women
and healthcare services, providing an ideal opportunity
for screening and intervention [36]. In practice, however,
this opportunity is all too often missed and perinatal
CMD too often remains undetected and untreated. If
implemented with sensitivity, screening for perinatal
CMD can help to identify women in need of support
and treatment [42, 43]. Current gaps in the evidence,
specifically around the validity of screening tools for
anxiety disorders, hinder the practice of screening peri-
natal women. More research in this area, including test-
ing the acceptability of instruments to the local
population, is essential to guide practice and inform
policy-makers on evidence-based means of identifying
women with CMD at an early stage.
To our knowledge, this is the first review of validation
studies for perinatal CMD in India. Strengths include
broad search terms, a comprehensive database search
without language or date restrictions and a thorough
grey literature search. Throughout the title and abstract
screening stages, we applied an inclusive approach: any
study referring to more than one assessment tool for
CMD in the title or abstract was included in full-text
screening even when it was not labelled as a validation
study in order to check for any relevant data. Additional
data from authors enabled us to calculate sensitivity and
specificity for all studies at a common threshold of ≥13.
A limitation of the review is its restriction to CMD, so
that other mental health disorders such as psychotic dis-
orders were excluded.
Conclusion
CMDs experienced during pregnancy and the postpar-
tum period all too often remain undetected and un-
treated, causing suffering, distress and disability for
affected women and their families. Screening tools which
have been validated and are appropriate to the local set-
ting and population are important to improve the identi-
fication of women with perinatal depression and anxiety
disorders. Evidence about the validity of screening tools
for perinatal CMD in India is limited: existing studies
focus exclusively on perinatal depression and exclusively
on the EPDS. The EPDS performed well as a screening
tool for perinatal depression and in the absence of local
validation to establish an optimal threshold, a standar-
dised cut-off from similar settings could be considered
as a next best alternative. Comparisons of the EPDS with
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other depression screening tools are needed to establish
which tool is most appropriate in Indian settings and
guide practitioners and policy-makers. The lack of re-
search on perinatal anxiety screening tools represents a
significant evidence gap which must be addressed. In-
creasing the detection of perinatal mental disorders is
key to better supporting women’s mental wellbeing and,
ultimately, improving maternal morbidity in India.
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